TP53 and cancer: Local hypermethylation of tumor suppressor promoters in cancer can also disrupt cancer-related cellular pathways, such as DNA repair, cell cycle, P53 network, apoptosis, Ras signaling, and Wnt signaling (Pan et al., 2021).